Wheal and flare responses to muscl relaxants in humans
Authors:
- 1 November 1991
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 34 (3-4) , 302-308
Abstract
Chemically and pharmacologically unrelated molecules release histamine in humans to produce both cutaneous and systemic responses. It has been suggested that molecular changes in the new benzylisoquinoline-derived muscle relaxant, atracurium, make it less likely to cause histamine release. We therefore injected volunteers intradermally with equimolar concentrations of various muscle relaxants, morphine, papaverine (a benzylisoquinoline), and histamine, to evaluate the relative ability of these drugs to cause wheal and flare responses, and mast-cell degranulation. There were no significant differences in wheal and flare responses among the three benzylisoquinoline-derived muscle relaxants,d-tubocurarine, metocurine, and atracurium. The cutaneous effects of morphine were significantly greater than those of the benzylisoquinoline muscle relaxants, suggesting both direct vascular changes and histamine release. Papaverine injection was followed by a significant wheal but no flare. Skin biopsies from vecuronium- and papaverine-induced wheals revealed normal intact mast-cell granules, suggesting a direct cutaneous vascular response rather than histamine release. Skin biopsies after morphine and atracurium injections revealed mast-cell degranulation. All evaluated benzylisoquinoline muscle relaxants are equipotent histamine releasers at equimolar concentrations. A hydrogenated, benzylisoquinoline-nitrogen-containing ring, present in atracurium but not in papaverine, appears to be the molecular conformation responsible for mast-cell degranulation by atracurium.Keywords
This publication has 25 references indexed in Scilit:
- Perioperative uses of histamine antagonistsJournal of Clinical Anesthesia, 1990
- Wheal and Flare Responses to Opioids in HumansAnesthesiology, 1989
- Allergy to suxamethonium: persisting abnormalities in skin tests, specific IgE antibodies and leucocyte histamine releaseClinical & Experimental Allergy, 1987
- Plasma histamine levels following atracuriumAnaesthesia, 1986
- Leukocyte histamine release to suxamethonium in patients with adverse reactions to muscle relaxantsJournal of Allergy and Clinical Immunology, 1985
- Functional Characteristics of Mucosal and Connective Tissue Mast Cells of Man, the Rat and Other AnimalsInternational Archives of Allergy and Immunology, 1985
- DETECTION OF IgE ANTIBODIES TO SUXAMETHONIUM AFTER ANAPHYLACTOID REACTIONS DURING ANAESTHESIAThe Lancet, 1984
- Intradermal Histamine Release by 3 Muscle RelaxantsActa Anaesthesiologica Scandinavica, 1983
- Role of Histamine in the Hypotensive Action of d-Tubocurarine in HumansAnesthesiology, 1981
- Intradermal Histamine Releasing Effect Caused by Org‐NC 45 A Comparison with Pancuronium, Metocurine and d‐TubocurarineActa Anaesthesiologica Scandinavica, 1980